Silence Therapeutics, Plc./ GB00B9GTXM62 /
| 11/23/2022 9:58:19 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 3.2500USD | - | 200 Turnover: 650 |
-Bid Size: - | -Ask Size: - | 3.2500 | 3.2500 |
GlobeNewswire
1/5/2022
Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright BioConnect Virtual Conferenc...
GlobeNewswire
12/12/2021
New Data from SLN124 Healthy Volunteer Study Reinforce Broad Therapeutic Potential in Hematological ...
GlobeNewswire
10/21/2021
Silence Therapeutics Provides mRNAi GOLD™ Platform and Pipeline Updates at 2021 R&D Day
GlobeNewswire
10/15/2021
Silence Announces Proposed Cancellation of Admission of its Ordinary Shares to Trading on AIM and Tr...
GlobeNewswire
10/15/2021
Silence Therapeutics and Hansoh Pharma Announce Collaboration to Develop Therapeutics Leveraging Sil...
GlobeNewswire
9/28/2021
Silence Therapeutics to Participate in Fireside Chat at the Chardan Virtual Genetic Medicines Confer...
GlobeNewswire
9/1/2021
Silence Therapeutics Appoints Dr. John Strafford as Senior Vice President, Business Development, All...
GlobeNewswire
5/25/2021
Silence Therapeutics Receives Remaining $40 Million from AstraZeneca as Part of Upfront Investment f...
GlobeNewswire
5/19/2021
Silence Therapeutics Announces Positive Data from GEMINI Phase 1 Study of SLN124 in Healthy Voluntee...
GlobeNewswire
5/12/2021
Silence Therapeutics to Participate in Fireside Chat at the RBC Capital Markets Global Healthcare Co...
GlobeNewswire
5/4/2021
Silence Therapeutics Launches New Video Game to Support International Thalassemia Day and Raise Dise...
GlobeNewswire
4/28/2021
Silence Therapeutics Achieves Another Research Milestone Payment from Mallinckrodt Collaboration for...
GlobeNewswire
4/15/2021
Silence Therapeutics Announces Publication in Cardiovascular Research Highlighting the Emerging Pote...
GlobeNewswire
4/7/2021
Silence Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference